Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum-free mesenchymal stem/stromal cell secretomes induce embryonic stem cell gastruloid formation and cardiomyocyte development.

Biochemical and biophysical research communications·2026
Same author

The FACT complex associates with the RPA complex at viral replication compartments to promote adenovirus infection.

Journal of virology·2026
Same author

<i>PENK</i> methylation and non-invasive bladder cancer detection.

Translational andrology and urology·2026
Same author

Development of an extended version of GALEAS bladder: Detection of FGFR3 fusions in urine and associations between genomic alterations and gene expression.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomes.

Biochemistry and biophysics reports·2026
Same author

Short-Term Outcomes of Arterial Divestment in Pancreatic Cancer: A Systematic Review and Single Arm Meta-Analysis of Observational Studies.

World journal of surgery·2026

Related Experiment Video

Updated: Jul 6, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Increased hepcidin expression in colorectal carcinogenesis.

Douglas G Ward1, Keith Roberts, Matthew J Brookes

  • 1CRUK Institute for Cancer Studies, University of Birmingham, Vincent Drive, Birmingham B15 2TH, United Kingdom.

World Journal of Gastroenterology
|March 7, 2008
PubMed
Summary
This summary is machine-generated.

Hepcidin, an iron regulator, is not linked to colorectal cancer anemia but is expressed in tumors, suggesting a new role in cancer growth. This finding impacts understanding of colorectal cancer progression.

More Related Videos

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

Related Experiment Videos

Last Updated: Jul 6, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
07:32

Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software

Published on: April 12, 2024

Area of Science:

  • Biochemistry
  • Oncology
  • Gastroenterology

Background:

  • Anemia is common in colorectal cancer patients.
  • Hepcidin is the primary regulator of systemic iron homeostasis.
  • The role of hepcidin in colorectal cancer pathogenesis is unclear.

Purpose of the Study:

  • To investigate hepcidin's role in colorectal cancer-associated anemia.
  • To explore hepcidin's potential involvement in colorectal carcinogenesis.

Main Methods:

  • Mass spectrometry (MALDI-TOF MS, SELDI-TOF MS) measured urinary hepcidin.
  • Quantitative Real Time RT-PCR assessed hepcidin mRNA in tumor tissue.
  • Immunohistochemistry determined hepcidin cellular localization.

Main Results:

  • Urinary hepcidin did not correlate with anemia but associated with higher colorectal cancer T-stage.
  • Hepcidin mRNA was found in 34% of colorectal cancer tissues, linked to ferroportin repression.
  • Hepcidin immunoreactivity confirmed its presence in tumor tissue.

Conclusions:

  • Systemic hepcidin is unlikely to cause anemia in colorectal cancer.
  • Hepcidin expression in colorectal cancer tissue suggests a novel oncogenic signaling mechanism.
  • This study offers new insights into the molecular mechanisms of colorectal cancer.